Frontotemporal brain sagging syndrome
Neurol 76:1377-1382, Wicklund, M.R.,et al, 2011
A Woman With Multifocal Ischemic Strokes and Progressive Cognitive Impairment Due to Intravascular Lymphoma
Stroke 54:e488-e451, Stamm,B., et al, 2023
FDG-PET/CT of Giant Cell Arteritis with Normal Inflammatory Markers
Ann Neurol 92:337-339, Koizumi, N.,et al, 2022
Clinicopathologic Conference, Mycobacterium Tuberculosis Meningitis
NEJM 384:166-176, Case 1-2021, 2021
Cerebral Microbleeds
Stroke 52:2347-2355, Graff-Radford, J.,et al, 2021
Clinicopathologic Conference, Cushings syndrome due to a well-differentiated, low-grade thymic neuroendocrine tumor with corticotropin
NEJM 378:2322-2332, Case 18-2018, 2018
Role of Brain Imaging in Early Parkinsonism
BMJ 324:d638, Breen,D.P.,et al, 2011
FDG-PET a Pivotal Imaging Modality for Diagnosis of Stroke-Onset Intravascular Lymphoma
Arch Neurol 67:366-367, Yamada,S.,et al, 2010
Positron Emission Tomography in Diagnosis of Visual Variant Alzheimer Disease
J Neuro-Ophthalmol 29:149-150, Finelli,P.F., 2009
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
NEJM 344:710-719,763, Freed,C.R.,et al, 2001
Ischemic Core and Penumbra in Human Stroke
Stroke 30:93-99, Kaufmann,A.M.,et al, 1999
Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998
Characterizing the Target of Acute Stroke Therapy
Stroke 28:866-872, Fisher,M., 1997
Clinical/Metabolic Correlations in Multiple System Atrophy, A PET Study
Arch Neurol 52:179-185, Perani,D.,et al, 1995
Neurological Sequelae of Cyanide Intoxication-The Patterns of Clinical MRI & Pet Findings
Ann Neurol 38:825-828, Rosenow,F.,et al, 1995
Complementary Positron Emission Tomographic Studies of the Striatal Dopaminergic System in Parkinson's Disease
Arch Neurol 52:1183-1190, Antonini,A.,et al, 1995
Early Differential Diagnosis of Parkinson's Disease with F-flurodeoxyglucose and Positron Emission Tomography
Neurol 45:1995-2004, Eidelberg,D.,et al, 1995
Clinical and[18F]dopa PET Findings in Early Parkinson's Disease
JNNP 59:597-600, Morrish,P.K.,et al, 1995
Demetia with Leucoaraiosis and Dural Arteriovenous Malformation:Clinical and PET Case Study
JNNP 56:929-931, Nencini,P.,et al, 1994
Callosal Atrophy with Reduced Cortical Oxygen Metabolism in Carotid Artery Disease
Stroke 24:88-93, Yamauchi,H.,et al, 1993
PET Imaging of the Dopamine Transporter with 11C-WIN 35, 428 Reveals Marked Declines in Mild Parkinson's Disease
Ann Neurol 34:423-431, Frost,J.J.,et al, 1993
Hypertensive Encephalopathy:Findings on CT, MR Imaging, and SPECT Imaging in 14 Cases
AJR 159:379-383, Schwartz,R.B.,et al, 1992
Preclinical Detection of Parkinson's Disease
Neurology Suppl 2, 41:5-921991., Koller,W.C.&Langston,J.W., 1991
Plasticity in the Aging Brain
Arch Neurol 47:1336-1341, Kaye,J.A.,et al, 1990
Cerebral Glucose Metabolism in the Course of Subacute Sclerosing Panencephalitis
Arch Neurol 46:97-100, Huber,M.,et al, 1989
Normal-Pressure Hydrocephalus and the Saga of the Treatable Dementias
JAMA 262:2577-2581, 2592-25931989., Friedland,R.P., 1989
Lesions of the Putamen:Their Relevance to Dystonia
Neurol 37:1125-1129, Fross,R.D.,et al, 1987
Borderzone Ischemia
Ann Neurol 22:707-713, Leblanc,R.,et al, 1987
Normal Pressure Hydrocephalus
BMJ 293:837-838, Anderson,M., 1986
Brain Dopamine Metabolism in Patients with Parkinson's Disease Measured with Positron Emission Tomography
JNNP 49:853-860, Leenders,K.L.,et al, 1986
Positron Emission Tomography with (18F) Fluorodeoxyglucose Diff. Normal Pressure Hydroceph from Alzheimer-Type Dementia
JNNP 48:1091-1096, Jagust,W.J.,et al, 1985